Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-12

Clinical Trial Update: Ischemia Reperfusion: Prostaglandins and Antioxidants [NA]

View source ↗

Summary

A University of Essex-sponsored trial investigating prostaglandins and antioxidants for ischemia-reperfusion injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Essex | Conditions: Ischemic Reperfusion Injury | NA | Status: COMPLETED